

[ Thu, Sep 19th 2024
] - WOPRAI

[ Mon, Sep 16th 2024
] - WOPRAI

[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI

[ Wed, Jul 31st 2024
] - WOPRAI

[ Mon, Jul 08th 2024
] - WOPRAI

[ Wed, Jul 03rd 2024
] - WOPRAI

[ Tue, Jun 18th 2024
] - WOPRAI

[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI

[ Thu, Mar 21st 2024
] - WOPRAI

[ Wed, Feb 28th 2024
] - WOPRAI

[ Fri, Oct 27th 2023
] - WOPRAI

[ Fri, Aug 11th 2023
] - WOPRAI

[ Mon, Jun 12th 2023
] - WOPRAI

[ Fri, Jun 02nd 2023
] - WOPRAI

[ Fri, May 26th 2023
] - WOPRAI

[ Mon, May 15th 2023
] - WOPRAI

[ Thu, May 11th 2023
] - WOPRAI

[ Tue, May 09th 2023
] - WOPRAI

[ Mon, May 08th 2023
] - WOPRAI

[ Fri, Mar 24th 2023
] - WOPRAI

[ Fri, Feb 03rd 2023
] - WOPRAI


[ Mon, Nov 14th 2022
] - WOPRAI

[ Thu, Nov 10th 2022
] - WOPRAI


[ Tue, Sep 06th 2022
] - WOPRAI

[ Fri, Jul 08th 2022
] - WOPRAI

[ Tue, Apr 12th 2022
] - WOPRAI

[ Fri, Jan 28th 2022
] - WOPRAI

[ Thu, Dec 02nd 2021
] - WOPRAI

[ Wed, Sep 29th 2021
] - WOPRAI

[ Wed, Mar 24th 2021
] - WOPRAI

[ Fri, Jan 25th 2019
] - WOPRAI
Matthew Biegler Maintained (TYRA) at Buy with Increased Target to $33 on, Sep 19th, 2024
Matthew Biegler of Oppenheimer, Maintained "Tyra Biosciences, Inc." (TYRA) at Buy with Increased Target from $25 to $33 on, Sep 19th, 2024.
Matthew has made no other calls on TYRA in the last 4 months.
There are 3 other peers that have a rating on TYRA. Out of the 3 peers that are also analyzing TYRA, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Matthew
- Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $33 on, Thursday, August 15th, 2024
- Robert Driscoll of "Wedbush" Reiterated at Buy and Held Target at $28 on, Thursday, August 8th, 2024
- Mitchell Kapoor of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $23 on, Wednesday, July 3rd, 2024